Bone Marrow-derived Dendritic Cell (BMDC) Preparation
3:25
T Cell Syngeneic Proliferation Assay
7:26
Results: Representative Tolerogenic DC (TolDC) Analyses
8:53
Conclusion
Transkript
The overall goal of this protocol is to develop and characterize murine tolerogenic dendritic cells for the evaluation of their immunotherapeutic utility in the treatment of autoimmune disorders, such as multiple sclerosis. This method can help an
Bu içeriğe erişmek için giriş yapın veya ücretsiz denemenizi başlatın
Here, we present a protocol to develop and characterize tolerogenic dendritic cells (TolDCs) and evaluate their immunotherapeutic utility.